4-68816419-A-C
Variant summary
Our verdict is Uncertain significance. Variant got 2 ACMG points: 4P and 2B. PM1PM2BP4_Moderate
The NM_001075.6(UGT2B10):āc.400A>Cā(p.Lys134Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,612,798 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001075.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
UGT2B10 | NM_001075.6 | c.400A>C | p.Lys134Gln | missense_variant | 1/6 | ENST00000265403.12 | NP_001066.1 | |
UGT2B10 | NM_001144767.3 | c.400A>C | p.Lys134Gln | missense_variant | 1/6 | NP_001138239.1 | ||
UGT2B10 | XM_017008585.3 | c.400A>C | p.Lys134Gln | missense_variant | 1/6 | XP_016864074.1 | ||
UGT2B10 | NM_001290091.2 | c.-27+247A>C | intron_variant | NP_001277020.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.00000658 AC: 1AN: 151898Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00000804 AC: 2AN: 248816Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 134988
GnomAD4 exome AF: 0.00000479 AC: 7AN: 1460900Hom.: 0 Cov.: 34 AF XY: 0.00000826 AC XY: 6AN XY: 726766
GnomAD4 genome AF: 0.00000658 AC: 1AN: 151898Hom.: 0 Cov.: 32 AF XY: 0.0000135 AC XY: 1AN XY: 74202
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 07, 2023 | The c.400A>C (p.K134Q) alteration is located in exon 1 (coding exon 1) of the UGT2B10 gene. This alteration results from a A to C substitution at nucleotide position 400, causing the lysine (K) at amino acid position 134 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at